|Founded||Warsaw, Indiana, U.S. (1927)|
|Headquarters||Warsaw, Indiana, USA|
|Key people||David C Dvorak (President/CEO)|
|Revenue||US$ 4.45 billion (2011)|
Zimmer Holdings Inc. (NYSE: ZMH) is a publicly traded medical device company. It was founded in 1927 by Robert H. Zimmer to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
In 2001 Zimmer was spun off from Bristol-Myers Squibb and begins trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the Company acquired ExtraOrtho, Inc. (ExtraOrtho). In January 2012, the Company acquired Reno, Nevada-based Synvasive Technology, Inc.
Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related orthopaedic surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries.
Zimmer's 2009 sales were approximately $4.095 billion, slightly less than its high of $4.121 billion, in 2008. The company is supported by the efforts of approximately 8,200 employees worldwide, 4,900 of whom reside in the United States and 3,300 of whom are outside the U.S., primarily in Europe and Japan.
Zimmer leadership includes the following individuals:
- David C Dvorak, President/CEO
- Jeffery A McCaulley, Pres:Zimmer Reconstructive
- Joseph A Cucolo, Pres:Americas Sales
- James T Crines, Exec VP:Finance/CFO
- Chad F Phipps, Senior VP/Secretary/Gen Cnsl
- Robert J Marshall Jr "Bob", VP:Investor Relations
- Simon, Hermann, Hidden Champions of the 21st Century: Success Strategies of unknown World Market Leaders, London: Springer, 2009, ISBN 978-0-387-98147-5
- "Zimmer Holdings, Inc 2009 Annual Report". Retrieved 12 December 2010.
- "Company Profile for Zimmer Holdings Inc (ZMH), Bloomberg".
|This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it.|